Ningetinib in Advanced NSCLC Skipping Mutations With MET Exon 14 Skipping Mutations

NCT04992858 · clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class

Stopped Withdrawn proactively due to the company's development strategy adjustment and changes in the drug R\&D direction.

Conditions

Interventions

Sponsor

Sunshine Lake Pharma Co., Ltd.